AI-based solution to quickly identify the best option for each application from billions of possible proteins
Exazyme has raised €2.0M across 1 funding round from 2 investors, most recently a round in May 2023. Based in Berlin, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-05-15 | Other | €2.0M |
| AIX Ventures,Atlantic Labs |
| View deal → |
